Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study
A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total
- Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study
A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total
- Clinical Study Finds Ginkgo Extract EGb 761(R) Improves Quality of Life of Typical Alzheimer's Patients
Results of the double-blind, placebo-controlled trial were presented at the 21st International Conference of Alzheimer's Disease International, indicate that Ginkgo biloba extract EGb 761(R) (manufactured by the Dr. Willmar Schwabe Company), improve cognitive functions, neuropsychiatric symptoms and the ability to perform daily living activities among typical Alzheimer's patients.
- Clinical Study Finds Ginkgo Extract EGb 761(R) Improves Quality of Life of Typical Alzheimer's Patients
Results of the double-blind, placebo-controlled trial were presented at the 21st International Conference of Alzheimer's Disease International, indicate that Ginkgo biloba extract EGb 761(R) (manufactured by the Dr. Willmar Schwabe Company), improve cognitive functions, neuropsychiatric symptoms and the ability to perform daily living activities among typical Alzheimer's patients.
- Clinical Study Finds Ginkgo Extract EGb 761(R) Improves Quality of Life of Typical Alzheimer's Patients
Results of the double-blind, placebo-controlled trial were presented at the 21st International Conference of Alzheimer's Disease International, indicate that Ginkgo biloba extract EGb 761(R) (manufactured by the Dr. Willmar Schwabe Company), improve cognitive functions, neuropsychiatric symptoms and the ability to perform daily living activities among typical Alzheimer's patients.
- Clinical Study Finds Ginkgo Extract EGb 761(R) Improves Quality of Life of Typical Alzheimer's Patients
Results of the double-blind, placebo-controlled trial were presented at the 21st International Conference of Alzheimer's Disease International, indicate that Ginkgo biloba extract EGb 761(R) (manufactured by the Dr. Willmar Schwabe Company), improve cognitive functions, neuropsychiatric symptoms and the ability to perform daily living activities among typical Alzheimer's patients.
- Clinical Study Finds Ginkgo Extract EGb 761(R) Improves Quality of Life of Typical Alzheimer's Patients
Results of the double-blind, placebo-controlled trial were presented at the 21st International Conference of Alzheimer's Disease International, indicate that Ginkgo biloba extract EGb 761(R) (manufactured by the Dr. Willmar Schwabe Company), improve cognitive functions, neuropsychiatric symptoms and the ability to perform daily living activities among typical Alzheimer's patients.
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Body Of Science Supporting Astaxanthin For Eye Fatigue Reaches Critical Mass
According to the company, there are now seven published human clinical studies relating astaxanthin to this benefit, all performed using AstaREAL® natural astaxanthin.
- Body Of Science Supporting Astaxanthin For Eye Fatigue Reaches Critical Mass
According to the company, there are now seven published human clinical studies relating astaxanthin to this benefit, all performed using AstaREAL® natural astaxanthin.
- Body Of Science Supporting Astaxanthin For Eye Fatigue Reaches Critical Mass
According to the company, there are now seven published human clinical studies relating astaxanthin to this benefit, all performed using AstaREAL® natural astaxanthin.
- Body Of Science Supporting Astaxanthin For Eye Fatigue Reaches Critical Mass
According to the company, there are now seven published human clinical studies relating astaxanthin to this benefit, all performed using AstaREAL® natural astaxanthin.
- Glucosamine Studied in Mouse Model of Multiple Sclerosis
Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk.
- Glucosamine Studied in Mouse Model of Multiple Sclerosis
Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk.
- Glucosamine Studied in Mouse Model of Multiple Sclerosis
Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk.
- Glucosamine Studied in Mouse Model of Multiple Sclerosis
Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk.
- Glucosamine Studied in Mouse Model of Multiple Sclerosis
Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- Study Examines Ability of Vitamin To Help Treatment-resistant Asthma
Researchers from King's College London have found that vitamin D3 could substantially improve the responsiveness of these patients to steroid treatment for asthma attacks.
- Study Examines Ability of Vitamin To Help Treatment-resistant Asthma
Researchers from King's College London have found that vitamin D3 could substantially improve the responsiveness of these patients to steroid treatment for asthma attacks.
- Study Examines Ability of Vitamin To Help Treatment-resistant Asthma
Researchers from King's College London have found that vitamin D3 could substantially improve the responsiveness of these patients to steroid treatment for asthma attacks.
- Study Examines Ability of Vitamin To Help Treatment-resistant Asthma
Researchers from King's College London have found that vitamin D3 could substantially improve the responsiveness of these patients to steroid treatment for asthma attacks.
- Vitamin D Can Play Role in Lung Health
study in the December issue of CHEST shows that patients with higher concentrations of vitamin D had significantly better lung function, compared with patients with lower concentrations of vitamin D.
- Vitamin D Can Play Role in Lung Health
study in the December issue of CHEST shows that patients with higher concentrations of vitamin D had significantly better lung function, compared with patients with lower concentrations of vitamin D.
- Vitamin D Can Play Role in Lung Health
study in the December issue of CHEST shows that patients with higher concentrations of vitamin D had significantly better lung function, compared with patients with lower concentrations of vitamin D.
- Vitamin D Can Play Role in Lung Health
study in the December issue of CHEST shows that patients with higher concentrations of vitamin D had significantly better lung function, compared with patients with lower concentrations of vitamin D.
- High Intake Of Dietary Fiber Not Associated With Reduced Risk Of Colorectal Cancer
study in the December 14 issue of JAMA examines data from 13 studies, and shows most prospective cohort studies have found no association between dietary fiber intake and risk of colorectal cancer or adenomas, and randomized clinical trials of dietary fiber supplementation have failed to show reductions in the recurrence of colorectal adenomas.
- High Intake Of Dietary Fiber Not Associated With Reduced Risk Of Colorectal Cancer
study in the December 14 issue of JAMA examines data from 13 studies, and shows most prospective cohort studies have found no association between dietary fiber intake and risk of colorectal cancer or adenomas, and randomized clinical trials of dietary fiber supplementation have failed to show reductions in the recurrence of colorectal adenomas.
- High Intake Of Dietary Fiber Not Associated With Reduced Risk Of Colorectal Cancer
study in the December 14 issue of JAMA examines data from 13 studies, and shows most prospective cohort studies have found no association between dietary fiber intake and risk of colorectal cancer or adenomas, and randomized clinical trials of dietary fiber supplementation have failed to show reductions in the recurrence of colorectal adenomas.
- High Intake Of Dietary Fiber Not Associated With Reduced Risk Of Colorectal Cancer
study in the December 14 issue of JAMA examines data from 13 studies, and shows most prospective cohort studies have found no association between dietary fiber intake and risk of colorectal cancer or adenomas, and randomized clinical trials of dietary fiber supplementation have failed to show reductions in the recurrence of colorectal adenomas.
- High Intake Of Dietary Fiber Not Associated With Reduced Risk Of Colorectal Cancer
study in the December 14 issue of JAMA examines data from 13 studies, and shows most prospective cohort studies have found no association between dietary fiber intake and risk of colorectal cancer or adenomas, and randomized clinical trials of dietary fiber supplementation have failed to show reductions in the recurrence of colorectal adenomas.
- Study Finds Common Supplement Helps To Reduce Cocaine Cravings
A new study funded by the National Institutes of Health (NIH) suggests that N-acetylcysteine (NAC) might act as an agent to modulate the effects of cocaine addiction.
- Study Finds Common Supplement Helps To Reduce Cocaine Cravings
A new study funded by the National Institutes of Health (NIH) suggests that N-acetylcysteine (NAC) might act as an agent to modulate the effects of cocaine addiction.
- Study Finds Common Supplement Helps To Reduce Cocaine Cravings
A new study funded by the National Institutes of Health (NIH) suggests that N-acetylcysteine (NAC) might act as an agent to modulate the effects of cocaine addiction.
- Study Finds Common Supplement Helps To Reduce Cocaine Cravings
A new study funded by the National Institutes of Health (NIH) suggests that N-acetylcysteine (NAC) might act as an agent to modulate the effects of cocaine addiction.
- University Study Validates Patented Maitake Extract’s Superior Immunostimulating Properties
Study published in the Journal of the American Nutraceutical Association compared the immunostimulating properties of two different maitake mushroom glucan extracts, one being MaitakeGold 404®, against Lentinan, a pharmaceutical which contains a standard, well-researched mushroom derived glucan.
- University Study Validates Patented Maitake Extract’s Superior Immunostimulating Properties
Study published in the Journal of the American Nutraceutical Association compared the immunostimulating properties of two different maitake mushroom glucan extracts, one being MaitakeGold 404®, against Lentinan, a pharmaceutical which contains a standard, well-researched mushroom derived glucan.
- University Study Validates Patented Maitake Extract’s Superior Immunostimulating Properties
Study published in the Journal of the American Nutraceutical Association compared the immunostimulating properties of two different maitake mushroom glucan extracts, one being MaitakeGold 404®, against Lentinan, a pharmaceutical which contains a standard, well-researched mushroom derived glucan.
- University Study Validates Patented Maitake Extract’s Superior Immunostimulating Properties
Study published in the Journal of the American Nutraceutical Association compared the immunostimulating properties of two different maitake mushroom glucan extracts, one being MaitakeGold 404®, against Lentinan, a pharmaceutical which contains a standard, well-researched mushroom derived glucan.
- Study Shows Pine Tree Bark Improves Blood Circulation, Treats Venous Ulcers
Double-blind, placebo-controlled study, published in the November/December 2005 issue of Angiology, investigated the healing of venous ulcers in three groups: one group received placebo tablets, another group received Pycnogenol tablets and the final group received both Pycnogenol tablets and local topical treatment of the wound with Pycnogenol powder.
- Study Shows Pine Tree Bark Improves Blood Circulation, Treats Venous Ulcers
Double-blind, placebo-controlled study, published in the November/December 2005 issue of Angiology, investigated the healing of venous ulcers in three groups: one group received placebo tablets, another group received Pycnogenol tablets and the final group received both Pycnogenol tablets and local topical treatment of the wound with Pycnogenol powder.
- Study Shows Pine Tree Bark Improves Blood Circulation, Treats Venous Ulcers
Double-blind, placebo-controlled study, published in the November/December 2005 issue of Angiology, investigated the healing of venous ulcers in three groups: one group received placebo tablets, another group received Pycnogenol tablets and the final group received both Pycnogenol tablets and local topical treatment of the wound with Pycnogenol powder.
- Study Shows Pine Tree Bark Improves Blood Circulation, Treats Venous Ulcers
Double-blind, placebo-controlled study, published in the November/December 2005 issue of Angiology, investigated the healing of venous ulcers in three groups: one group received placebo tablets, another group received Pycnogenol tablets and the final group received both Pycnogenol tablets and local topical treatment of the wound with Pycnogenol powder.
- Nutrient Supplementation Reduces Irregular Heartbeat (Arrhythmia) in Patients
A randomized, double-blind, placebo-controlled, multi-center study, published in the November 2005 issue of JANA, indicates that nutrient supplementation led to a statistically significant decrease in the frequency of clinically apparent arrhythmic episodes, with further improvement in frequency over time.
- Nutrient Supplementation Reduces Irregular Heartbeat (Arrhythmia) in Patients
A randomized, double-blind, placebo-controlled, multi-center study, published in the November 2005 issue of JANA, indicates that nutrient supplementation led to a statistically significant decrease in the frequency of clinically apparent arrhythmic episodes, with further improvement in frequency over time.
- Nutrient Supplementation Reduces Irregular Heartbeat (Arrhythmia) in Patients
A randomized, double-blind, placebo-controlled, multi-center study, published in the November 2005 issue of JANA, indicates that nutrient supplementation led to a statistically significant decrease in the frequency of clinically apparent arrhythmic episodes, with further improvement in frequency over time.
- Nutrient Supplementation Reduces Irregular Heartbeat (Arrhythmia) in Patients
A randomized, double-blind, placebo-controlled, multi-center study, published in the November 2005 issue of JANA, indicates that nutrient supplementation led to a statistically significant decrease in the frequency of clinically apparent arrhythmic episodes, with further improvement in frequency over time.
- Nutrient Supplementation Reduces Irregular Heartbeat (Arrhythmia) in Patients
A randomized, double-blind, placebo-controlled, multi-center study, published in the November 2005 issue of JANA, indicates that nutrient supplementation led to a statistically significant decrease in the frequency of clinically apparent arrhythmic episodes, with further improvement in frequency over time.
- Vitamin D Supplementation During Pregnancy Could Reduce Osteoporosis In Children
Study published in this week’s issue of
The Lancet indicates that children whose mothers were lacking in vitamin D during
pregnancy grow up to have weaker bones.
- Vitamin D Supplementation During Pregnancy Could Reduce Osteoporosis In Children
Study published in this week’s issue of
The Lancet indicates that children whose mothers were lacking in vitamin D during
pregnancy grow up to have weaker bones.
- Vitamin D Supplementation During Pregnancy Could Reduce Osteoporosis In Children
Study published in this week’s issue of
The Lancet indicates that children whose mothers were lacking in vitamin D during
pregnancy grow up to have weaker bones.
- Vitamin D Supplementation During Pregnancy Could Reduce Osteoporosis In Children
Study published in this week’s issue of
The Lancet indicates that children whose mothers were lacking in vitamin D during
pregnancy grow up to have weaker bones.
- Research Examines Effect of Enzymotec Product on Children's Cognitive Performance
Double-blind, placebo-controlled clinical study conducted at the Tel-Aviv Sourasky Medical Center on 90 ADHD children indicates lipid-based product significantly improves cognitive performance.
- Research Examines Effect of Enzymotec Product on Children's Cognitive Performance
Double-blind, placebo-controlled clinical study conducted at the Tel-Aviv Sourasky Medical Center on 90 ADHD children indicates lipid-based product significantly improves cognitive performance.
- Research Examines Effect of Enzymotec Product on Children's Cognitive Performance
Double-blind, placebo-controlled clinical study conducted at the Tel-Aviv Sourasky Medical Center on 90 ADHD children indicates lipid-based product significantly improves cognitive performance.
- Research Examines Effect of Enzymotec Product on Children's Cognitive Performance
Double-blind, placebo-controlled clinical study conducted at the Tel-Aviv Sourasky Medical Center on 90 ADHD children indicates lipid-based product significantly improves cognitive performance.
- Research Examines Effect of Enzymotec Product on Children's Cognitive Performance
Double-blind, placebo-controlled clinical study conducted at the Tel-Aviv Sourasky Medical Center on 90 ADHD children indicates lipid-based product significantly improves cognitive performance.
- Curry and Cauliflower Could Halt Prostate Cancer
Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth.
- Curry and Cauliflower Could Halt Prostate Cancer
Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth.
- Curry and Cauliflower Could Halt Prostate Cancer
Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth.
- Curry and Cauliflower Could Halt Prostate Cancer
Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth.
- Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink
Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories.
- Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink
Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories.
- Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink
Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories.
- Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink
Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories.
- Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink
Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories.
- Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink
Nestle has announced the release of their BOOST(R) Kid Essentials Nutritionally Complete Drink. The drink is designed to give probiotics, delivered through the BOOST Kid Essentials straw, and contains 25 essential vitamins and minerals, seven grams of protein, antioxidants and 244 calories.
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- Health Canada Releases January 2009 Issue of CARN
Health Canada has released their January 2009 issue of the Canadian Adverse Reaction Newsletter, which works to help alert "health professionals to potential signals detected through the review of case reports submitted to Health Canada."
- NPI Daily - Top of The News for January 8, 2009 - HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America
Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension; BBB Warns Consumers of Two Companies That Use Oprah, Other Celebrity Names, to Sell Supplements; HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America; dicentra Web Seminar on Challenges and Solutions for Registering a Probiotic Product with the NHPD; Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink; Health Canada Releases January 2009 Issue of CARN; What to Expect From the Nutrition Industry's Ingredient Supply Segment in 2009
- NPI Daily - Top of The News for January 8, 2009 - HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America
Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension; BBB Warns Consumers of Two Companies That Use Oprah, Other Celebrity Names, to Sell Supplements; HHS Officials Mark Opening of First U.S. Food and Drug Administration Office in Latin America; dicentra Web Seminar on Challenges and Solutions for Registering a Probiotic Product with the NHPD; Nestle Nutrition Launches BOOST® Kid Essentials Nutritionally Complete Drink; Health Canada Releases January 2009 Issue of CARN; What to Expect From the Nutrition Industry's Ingredient Supply Segment in 2009
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Something To Feel Good About: New Study Validates St. John's Wort Efficacy in Support against Depression
Bioforce USA has announced the results of a clinical survey of 200 patients suffering from mild to moderate depression and the effects of six weeks of taking St. Johns Wort (A. Vogel Hyperiforce) tablets. The year-long study (March 2006 to March 2007) recruited 33 physicians in private practices in Switzerland. The study looked at several factors of the state of depression itself: severity, anxiety and nervousness, as well as vegetative (physical/systemic) symptoms.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Proprietary Nutritionals to Distribute Sytrinol Heart Health Supplement
Dean Mosca, president of Proprietary Nutritionals, Inc., has announced that PNI will assume the exclusive worldwide distribution rights for Sytrinol®, effective Jan. 1, 2009.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
- Natural Products Association Advocates Strength of Dietary Supplement Law
The Natural Products Association's Executive Director and CEO, David Seckman, has released a statement in response to misleading statements recently made regarding dietary supplement regulation.
|
A diet rich in omega-3 fatty acids, such as those found in fish, canola oil, and walnuts, can have anti-inflammatory effects and improve the exercise capacity for patients with chronic obstructive pulmonary disease (COPD). For two years, Japanese researchers followed 32 patients with COPD on an omega-3 fatty acid-rich diet (treatment group) and 32 patients with COPD on a non-omega-3 fatty acid-rich diet (nontreatment group). Every three months, dyspnea scores, levels of inflammatory mediators, and exercise capacity were recorded. Overall, results showed that dyspnea scores and exercise capacity significantly improved and inflammatory mediators significantly decreased for patients in the treatment group, while there was no significant change in the nontreatment group. Researchers suggest that nutritional support with an omega-3 fatty acid-rich diet is a safe and practical method for treating COPD. The study appears in the December issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians. |